EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Swelling: Clinical Insights into the Diagnosis and Management of Hereditary Angioedema

Margarita Paulauskiene, Laura Tamasauskiene, Brigita Gradauskiene iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177680 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Margarita Paulauskiene und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania. Hauptthemen laut MEDLINE: Angioedemas, Hereditary. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe, non-pitting edema, most commonly caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), resulting in excessive bradykinin production. HAE subtypes differ according to C1-INH levels, functional activity, underlying genetic variants, and increasingly recognized molecular mechanisms. Awareness of HAE outside specialized medical fields remains limited, and recurrent angioedema may arise through different pathophysiological mechanisms, which together contribute to frequent misdiagnosis, particularly in patients without a positive family history. Consequently, many patients experience significant diagnostic delays and inappropriate interventions. Rapid advances in endotype-based classification, molecular diagnostics, and targeted therapies have substantially changed the understanding and management of HAE, highlighting the need for an updated clinical overview. This review provides a comprehensive overview of HAE classification, clinical presentation, genetic background, diagnosis, and current management. Particular attention is given to advances in diagnostic biomarkers and genetic testing, newly approved targeted therapies, and oral on-demand treatment. Together, these advances are moving HAE management toward earlier diagnosis, more individualized treatment, and more patient-centered care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioedemas, HereditaryHumansComplement C1 Inhibitor ProteinBradykininDisease ManagementBiomarkers

Stichwörter der Autor:innen

C1 esterase inhibitor deficiencyangioedemabradykininhereditary angioedemaswelling

Substanzen

Complement C1 Inhibitor ProteinBradykininBiomarkers

Autor:innen und Institutionen

  • Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania.
  • Laboratory of Immunology, Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania.

ORCID-Profile: Brigita Gradauskiene

Zitieren

APA

Paulauskiene, M., Tamasauskiene, L., & Gradauskiene, B. (2026). Beyond Swelling: Clinical Insights into the Diagnosis and Management of Hereditary Angioedema. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177680

Vancouver

Paulauskiene M, Tamasauskiene L, Gradauskiene B. Beyond Swelling: Clinical Insights into the Diagnosis and Management of Hereditary Angioedema. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177680

BibTeX
@article{Paulauskiene2026,
  author = {Paulauskiene, Margarita and Tamasauskiene, Laura and Gradauskiene, Brigita},
  title = {Beyond Swelling: Clinical Insights into the Diagnosis and Management of Hereditary Angioedema},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177680}
}
Kostenlos starten →